-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Strategy, Lowers Price Target to $125

Benzinga·08/03/2026 12:26:52
Listen to the news
Barclays analyst Nik Cremo maintains Strategy (NASDAQ:MSTR) with a Overweight and lowers the price target from $130 to $125.